发明名称 7-Heteroarylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
摘要 The invention provides compounds of formula (I): wherein A and B represent the groups -(CH<SUB>2</SUB>)<SUB>m</SUB>- and -(CH<SUB>2</SUB>)<SUB>n</SUB>- respectively; R<SUP>1 </SUP>represents hydrogen or C<SUB>1-6</SUB>alkyl; R<SUP>2 </SUP>represents hydrogen, halogen, hydroxy, cyano, nitro, hydroxyC<SUB>1-6</SUB>alkyl, trifluoromethyl, trifluoromethoxy, C<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkoxy, C<SUB>1-6</SUB>fluoroalkoxy, -(CH<SUB>2</SUB>)<SUB>p</SUB>C<SUB>3-6</SUB>cycloalkyl, -(CH<SUB>2</SUB>)<SUB>p</SUB>OC<SUB>3-6</SUB>cycloalkyl, -COC<SUB>1-6</SUB>alkyl, -SO<SUB>2</SUB>C<SUB>1-6</SUB>alkyl, -SOC<SUB>1-6</SUB>alkyl, -S-C<SUB>1-6</SUB>alkyl, -CO<SUB>2</SUB>C<SUB>1-6</SUB>alkyl, -CO<SUB>2</SUB>NR<SUP>3</SUP>R<SUP>4</SUP>, -SO<SUB>2</SUB>NR<SUP>3</SUP>R<SUP>4</SUP>, -(CH<SUB>2</SUB>)<SUB>p</SUB>NR<SUP>3</SUP>R<SUP>4</SUP>, -(CH<SUB>2</SUB>)<SUB>p</SUB>NR<SUP>3</SUP>COR<SUP>4</SUP>, optionally substituted aryl ring, optionally substituted heteroaryl ring, a fused bicyclic heteroaromatic ring system or optionally substituted heterocyclyl ring; Ar<SUP>1 </SUP>represents optionally substituted heteroaryl ring; Ar<SUP>2 </SUP>represents optionally substituted aryl ring or optionally substituted heteroaryl ring; Z represents -(CH<SUB>2</SUB>)<SUB>q</SUB>X- wherein the -(CH<SUB>2</SUB>)<SUB>q</SUB>- group is attached to Ar<SUP>2</SUP>, or -X(CH<SUB>2</SUB>)<SUB>q</SUB>- wherein X is attached to Ar<SUP>2</SUP>, and wherein any of the -CH<SUB>2</SUB>- groups may be optionally substituted by one or more C<SUB>1-6</SUB>alkyl groups; X represents oxygen, -CH(OR<SUP>5</SUP>)-, -NR<SUP>5</SUP>- or -CH<SUB>2</SUB>- wherein the -CH<SUB>2</SUB>- group may be optionally substituted by one or more C<SUB>1-6</SUB>alkyl groups; R<SUP>3 </SUP>and R<SUP>4 </SUP>each independently represent hydrogen, C<SUB>1-6</SUB>alkyl or, together with the nitrogen or other atoms to which they are attached, form an azacycloalkyl ring or an oxo-substituted azacycloalkyl ring; R<SUP>5 </SUP>represents hydrogen or C<SUB>1-6</SUB>alkyl; m and n independently represent an integer selected from 1 and 2; p independently represents an integer selected from 0, 1, 2 and 3; q independently represents an integer selected from 0, 1, 2 and 3; or a pharmaceutically acceptable salt or solvate thereof, with the proviso that when Ar<SUP>1 </SUP>is a pyridyl group, and Z is -CH<SUB>2</SUB>X- where X is attached to the Ar<SUP>1 </SUP>group, X is selected from -CH(OR<SUP>5</SUP>)-, -NR<SUP>5</SUP>- and -CH<SUB>2</SUB>- wherein the -CH<SUB>2</SUB>- group may be optionally substituted by one or more C<SUB>1-6</SUB>alkyl groups. The compounds of formula (I) are useful in therapy, in particular as antipsychotic agents.
申请公布号 US2007093473(A1) 申请公布日期 2007.04.26
申请号 US20040571220 申请日期 2004.09.09
申请人 GLAXO GROUP LIMITED 发明人 COOPER DAVID G.;FORBES IAN T.;GARZYA VINCENZO;GRIBBLE ANDREW D.;LIGHTFOOT ANDREW P.;PAYNE ANDREW H.;SMITH ALEXANDER B.
分类号 A61K31/55;A61P25/18;C07D401/12;C07D403/02;C07D409/02;C07D409/12 主分类号 A61K31/55
代理机构 代理人
主权项
地址